Insight Advisors, LLC/ PA - OSMOTICA PHARMACEUTICALS PLC ownership

Quarter-by-quarter ownership
Insight Advisors, LLC/ PA ownership history of OSMOTICA PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$6,551
-84.5%
75,6460.0%0.00%
-88.9%
Q2 2023$42,369
-50.9%
75,6460.0%0.01%
-55.0%
Q1 2023$86,236
+98.3%
75,646
+100.0%
0.02%
+33.3%
Q4 2022$43,496
-44.9%
37,8230.0%0.02%
-51.6%
Q3 2022$79,000
+33.9%
37,8230.0%0.03%
+55.0%
Q2 2022$59,000
-7.8%
37,8230.0%0.02%
+5.3%
Q1 2022$64,000
+137.0%
37,823
+52.5%
0.02%
+137.5%
Q4 2021$27,000
-40.0%
24,8000.0%0.01%
-38.5%
Q3 2021$45,000
-47.1%
24,8000.0%0.01%
-51.9%
Q2 2021$85,000
+19.7%
24,8000.0%0.03%
+22.7%
Q1 2021$71,000
+16.4%
24,800
+67.6%
0.02%
-4.3%
Q4 2020$61,00014,8000.02%
Other shareholders
OSMOTICA PHARMACEUTICALS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,148,832$8,801,0003.14%
Rovida Advisors Inc. 3,000,000$3,210,0000.14%
Zebra Capital Management LLC 24,384$26,0000.04%
TITLEIST CAPITAL, LLC 80,184$87,0000.02%
Alyeska Investment Group, L.P. 1,125,689$1,216,0000.01%
ArrowMark Colorado Holdings LLC 1,000,000$1,080,0000.01%
Insight Advisors, LLC/ PA 24,800$27,0000.01%
Engineers Gate Manager LP 42,810$46,0000.00%
Renaissance Technologies 1,355,774$1,464,0000.00%
TWO SIGMA INVESTMENTS, LP 249,851$270,0000.00%
View complete list of OSMOTICA PHARMACEUTICALS PLC shareholders